港股異動 | 啤酒股強勢 華潤啤酒(0291.HK)大漲超7%領漲
格隆匯3月17日丨港股啤酒股普遍上揚,華潤啤酒大漲逾7%領銜走高,市值重回2千億港元上方,青島啤酒股份漲5.11%,百威亞太漲4.6%。德邦證券指出,展望2021年,一方面是競爭格局的優化,行業的提價預期強化,升級有望加速,另一方面今年延期的體育賽事在21年展開,將提振啤酒的旺季需求,推薦華潤啤酒等。商務部預計後期消費市場總體繼續呈現恢復性增長態勢,安信首推餐廳板塊,啤酒板塊亦值得關注。此外,華潤啤酒於3月22日舉行董事會會議審批年度業績。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.